Companies
- Companies
- Browse
Companies
Good Biotech Corporation (GBC) is a leading producer of industrial scale high-purity polyclonal IgY(-Fc) antibodies from duck egg yolk, offering a wide range of biotechnology applications. More
Viral Therapeutics Company - focused currently on HIV/AIDS More
Muti-disciplinary institute with neuroscience, cancer and cardiovascular research toghether with medicinal chemistry expertise More
BayernPatent offers a wide range of high quality patents from Bavarian universities. More
Commercial exploitation company of The University of Manchester More
PROCREA BioSciences Inc. is a biotech company involved in reproductive medicine and human genetics More
A leading biotech company in Korea specialized in the development of therapeutic antibody and clinical lab service More
Acts as an industrial catalyst through research and development in leading edge medical diagnostics More
Related Reports
Market Research Reports provided by reports.iptechex.com
May 2011 - 15 pages - $250
Jan 2010 - $75
Mar 2011 - 23 pages - $750
May 2006 - 74 pages - $2,500
May 2011 - 15 pages - $125
Feb 2011 - 11 pages - $995
Mar 2011 - 23 pages - $750
Dec 2010 - 37 pages - $500
Apr 2011 - 86 pages - $3,835
Sep 2010 - 25 pages - $125
Your selection
Browse By
- Therapeutic target
- Adoptive immunotherapy
- Amyloidosis
- Autoimmune disease (non-specific)
- Chronic fatigue syndrome
- Chronic granulomatous disease
- Chronic immunosuppression
- Gout
- Graft versus host disease
- HIV/AIDS
- Immune disorder (non-specific)
- Immune thrombocytopenic purpura
- Immunomodulation
- Immunostimulation
- Immunosuppression
- Lupus erythematosis
- Myalgic encephalomyelitis
- Myasthenia gravis
- Neoplastic disease
- Organ transplant rejection
- Rheumatoid arthritis
- Servere combined immunodeficency
- Sjogren's syndrome
- Systemic sclerosis
- Transplant rejection
- Xenotransplantation
- Geographic location
- Africa
- Asia
- Australia/New Zealand
- Central America
- Europe
- Near & Far East
- North America
- South America
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us